Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. (2021)
Attributed to:
MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/ s2665-9913(21)00061-8
PubMed Identifier: 33928262
Publication URI: http://europepmc.org/abstract/MED/33928262
Type: Journal Article/Review
Volume: 3
Parent Publication: The Lancet. Rheumatology
Issue: 5
ISSN: 2665-9913